Bayer Figured Out That Its AI Content Was Accidentally Advertising for Competitors. Most Brands Haven't Checked.

The quote that should bother every brand manager came from CreativeX CEO Anastasia Leng in a recent Adweek feature: "Brands aren't thinking carefully enough about how much of their media investment is actually inadvertently helping their competitors."

She wasn't talking about competitor conquesting or bid wars. She was talking about your own content. Specifically, the growing volume of AI-generated creative that looks professional, performs adequately on platform metrics, and is functionally interchangeable with what three other brands in your category are running.

Bayer, which operates across 80 countries with brands like Claritin, Alka Seltzer, and Aleve, apparently noticed this early enough to do something about it. Their response is worth examining, not because it's flashy, but because it's one of the few examples I've seen of a brand treating AI quality control as a competitive defense rather than a compliance checkbox.

The content production problem nobody wants to quantify

Here's the situation Bayer's global content and creative lead, Céline Baudin, described to Adweek: "We struggle sometimes to understand what kind of content we create across all our markets, and to ensure this is the content that is actually optimized and good quality."

That's an unusually honest admission from a company that size. And the word "sometimes" is doing a lot of work in that sentence. In 80 markets, with local teams adapting global campaigns, using AI to localize in different languages and cut assets to different lengths, "sometimes" probably means "often, and we're only catching the obvious problems."

The broader data suggests Bayer isn't an outlier. According to Smartly's 2026 Digital Advertising Trends report, 86% of marketers have already seen AI-generated outputs that resemble content from competitors. Three in four are concerned that AI creative risks making brands look and sound the same. And respondents estimated that roughly 20% of their annual digital marketing spend is wasted, though "Precision-First Marketers" who embed AI governance in their workflows report cutting that number significantly.

Twenty percent waste was bad enough when it was just poorly targeted impressions. Now it includes impressions where the creative itself is doing your competitor's job for them.

What Bayer actually built

Bayer implemented CreativeX's Creative Salience system, which scans content before publication against a set of brand-specific rules. CreativeX already offered a Creative Quality Score that evaluates whether assets are platform-suitable (right format, right specs, correct dimensions). The Salience layer goes deeper: is the content distinctly this brand?

Baudin shared a finding that surprised me, honestly. They discovered that content requires "three or four distinctive brand assets to have an impact." Not one logo. Not just brand colors. Three or four elements working together. And the placement matters enormously: putting your logo in the first three seconds is essential. Putting it at the end, which is what a lot of AI-generated video defaults to, "doesn't work."

That's a very specific, testable insight. And it implies something uncomfortable for teams relying on templated AI output: if your creative tool generates a clean, professional video with your logo slapped on the last frame, you might be spending money to remind viewers of the product category without reminding them of your brand.

The custom algorithm piece is just as important

Separately, Ad Age reported that Bayer's consumer health division partnered with Chalice AI and Snowflake to bring custom targeting algorithms in-house. The setup is worth understanding: Chalice AI built an app that operates within Bayer's Snowflake data clean room, so the brand can modify its targeting algorithm independently without moving sensitive data to an external partner.

The result they cited was a 6% sales lift for Claritin among new customers. Not a mind-blowing number in isolation, but significant when you consider that most brand advertisers are running the same automated bidding strategies against the same audiences in the same auction. A 6% lift from a custom algorithm in a category as commoditized as OTC allergy medication suggests the default approach is leaving real money on the table.

What connects both moves is a single philosophy: don't outsource the decisions that determine whether your media spending helps you or your competitors. Content quality is one layer. Targeting precision is another. Bayer is building proprietary defenses on both.

The problem for everyone who isn't Bayer-sized

I want to be honest here. Bayer has the budget and the infrastructure to deploy CreativeX at scale and run custom algorithms inside Snowflake data clean rooms. Most brands do not. A 15-person marketing team at a D2C brand is not going to replicate this stack.

But the underlying insight scales down pretty well. The question isn't "can you afford CreativeX?" It's "do you know whether your AI-generated content is distinctly yours?"

Here's a rough audit you can run this week:

Pull your last 20 AI-generated or AI-assisted ad creatives. Cover the logo. Show them to someone outside your team. Ask them to name the brand. If they can't tell yours from a competitor's, you have a brand salience problem, and you're spending money to teach audiences about a product category instead of your specific product.

Check logo and brand asset placement in your video content. If your brand identity only appears in the final seconds, test moving it to the first three seconds. Bayer found this matters. My read is that it matters even more for smaller brands with less existing brand recognition.

If you're using automated creative tools (and most paid social teams are at this point), review whether the tool is enforcing brand guidelines or just producing platform-compliant assets. Those are two very different things. A perfectly formatted Instagram Story that could belong to any of your five nearest competitors is not a well-performing ad. It's a donation to your category.

The agentic AI wrinkle nobody is preparing for

One more detail from the Ad Age piece: Bayer is explicitly preparing for agentic advertising, where AI systems could autonomously plan campaigns, identify audiences, and execute media trades without human intervention at each step.

That's the direction most large advertisers are heading. And it makes the brand asset question even more critical. When a human reviews creative before it goes live, there's at least a chance they'll catch a generic-looking asset. When an AI agent is producing, selecting, and deploying creative at speed, the content quality guardrails have to be baked into the system itself. You can't rely on someone eyeballing it before it ships.

From what I've seen, maybe 10% of marketing teams are thinking about this proactively. We wrote recently about how 42% of teams say AI actually increased their marketing costs, and creative quality governance is one of the reasons. Building guardrails is not free. But the alternative, spending money on creative that accidentally promotes your competitors, is more expensive. You just don't see it on the invoice.

Brand distinctiveness was supposed to be the solved part

The irony is that brand distinctiveness was the easy chapter. Colors, logos, trade dress, visual identity: solved problems with decades of brand management playbooks behind them.

AI content production has quietly unsolved them. The tools are fast, cheap, and good at generating professional-looking output. They are not particularly good at making that output feel like it could only have come from one brand. And the economics of scale incentivize more volume over more distinctiveness, which is a problem that compounds the longer you ignore it.

Bayer's bet is that defending brand assets in every piece of content, across every market, with automated scanning before publication, is worth the investment. IAS reports that while 61% of media professionals are excited about AI in advertising, 53% simultaneously flag content quality and brand adjacency as their top concern. Most of them are excited and worried about the same thing. Bayer is one of the few that seems to be actually doing something about it.

Given that 86% of their peers haven't even noticed how much their AI content resembles the competition, they're probably building a lead that'll take others a while to close.